Instead, differential expression analysis combined with TF regulatory analysis of the identified cytotoxic CD8+ T cell clusters revealed that treatment response is associated with enrichment of IFN signaling, which is in line with a study by Dey et al. [178] on MDS patients treated with AZA combined with anti-TIM-3 blockade. Here, CD8A is linked to myelodysplastic syndrome.